Board
The term of office of the Board of the GDCh Division of Medicinal Chemistry ends on 31 December 2026, and you, as members of the Division, are invited to nominate candidates for the Board election who
According to the Division's bylaws, the Board consists of a maximum of six members (1 Chair, 1 Deputy Chair, max. 4 ordinary members), each elected for a term of four years. Universities and industry should be equally represented on the Board. One re-election is permitted.
After serving two terms, Prof. Dr. Christian Ducho, Dr. Gerhard Heßler and Prof. Dr. Anna Hirsch are no longer eligible to stand for a further term. Unfortunately, Dr. Christian Kuttruff is not available for a further term of office. Dr. Tatjana Ross and Prof. Dr. Holger Stark have indicated that they are willing to stand for re-election. We would like to take this opportunity to thank them all for their many years of successful work for the Division and the GDCh as a whole.
For the six Board positions to be filled, the current Board, in addition to your nominations, puts forward the following six candidates:
University/research institution/public authority
| Name | Affiliation | Election status |
| Prof. Dr. Matthias Gehringer | Eberhard-Karls-Universität Tübingen | New election |
| Prof. Dr. Daniel Merk | Ludwig-Maximilians-Universität München | New election |
| Prof. Dr. Holger Stark | Heinrich-Heine-Universität Düsseldorf | Re-election |
Industry/self-employed professionals
| Name | Affiliation | Election status |
| Dr. Stefanie Flohr | Novartis AG, Basel (Switzerland) | New election |
| Dr. Felix Pape | Nuvisan Pharma Services Group, Berlin | New election |
| Dr. Tatjana Ross | Merck KGaA, Darmstadt | Re-election |
If no written proposals to nominate further candidates are received by the GDCh Office (for the attention of Maike Fries; m.fries@gdch.de) by 16 October 2026 inclusive, the election will be held Online from 2 November 2026 with the candidates listed above.
Dr. Gerhard Heßler (Chair), Sanofi-Aventis Deutschland, Frankfurt a.M.
Dr. Tatjana Ross (Deputy Chair), Merck KGaA, Darmstadt
Prof. Dr. Christian Ducho, Technical University of Braunschweig
Prof. Dr. Anna Hirsch, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Saarbrücken
Dr. Christian Kuttruff, Boehringer-Ingelheim International GmbH, Biberach
Prof. Dr. Holger Stark, Heinrich Heine University Düsseldorf
Permanent guest of the Executive Board
Prof. Dr. Louisa Temme, University of Hamburg (NextGenMedChem representative)
The term of office of the Board of the GDCh Division of Medicinal Chemistry ends on 31 December 2026, and you, as members of the Division, are invited to nominate candidates for the Board election who
Under the Division’s bylaws, the Board consists of a maximum of six members (1 Chair, 1 Deputy Chair and a maximum of 4 ordinary members), each elected for a term of four years. Universities and industry should be represented equally on the Board. Members may be re-elected once.
After serving two terms, Prof. Dr. Christian Ducho, Dr. Gerhard Heßler and Prof. Dr. Anna Hirsch are no longer eligible to stand for a further term. Unfortunately, Dr. Christian Kuttruff is not available for a further term of office. Dr. Tatjana Ross and Prof. Dr. Holger Stark have indicated that they are willing to stand for re-election. We would like to take this opportunity to thank them all for their many years of successful service to the Division and the GDCh as a whole.
For the six Board positions up for election, the current Board is putting forward the following six candidates, in addition to your nominations:
University/research institution/authority
| Name | Affiliation | Election status |
| Prof. Dr. Matthias Gehringer | Eberhard Karls University of Tübingen | New election |
| Prof. Dr. Daniel Merk | Ludwig Maximilian University of Munich | New election |
| Prof. Dr. Holger Stark | Heinrich Heine University Düsseldorf | Re-election |
Industry/self-employed professions
| Name | Affiliation | Election status |
| Dr. Stefanie Flohr | Novartis AG, Basel (Switzerland) | New election |
| Dr. Felix Pape | Nuvisan Pharma Services Group, Berlin | New election |
| Dr. Tatjana Ross | Merck KGaA, Darmstadt | Re-election |
If no written proposals to nominate additional candidates are received by the GDCh Office (for the attention of Maike Fries; m.fries@gdch.de) by 16 October 2026, the election will be held Online from 2 November 2026 with the candidates listed above.